New mRNA flu vaccine trial aims to stop future pandemics

NCT ID NCT06907511

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new mRNA vaccine designed to protect against a potential pandemic flu caused by the H5 virus. Healthy adults aged 18 and older will receive either a high, medium, or low dose of the vaccine or a placebo. The goal is to see if the vaccine is safe and triggers a strong immune response, helping to prepare for future outbreaks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Accel Research Site - NeuroStudies.net, LLC - ERN - PPDS- Site Number : 8400003

    Decatur, Georgia, 30030-2627, United States

  • Accel Research Sites - Lakeland Clinical Research Unit- Site Number : 8400006

    Lakeland, Florida, 33803, United States

  • Accel Research Sites - St. Petersburg - Largo- Site Number : 8400004

    Largo, Florida, 33777, United States

  • Accel Research Sites Network - DeLand Clinical Research Unit- Site Number : 8400002

    DeLand, Florida, 32720, United States

  • Charlottesville Medical Research- Site Number : 8400005

    Charlottesville, Virginia, 22911, United States

  • Coastal Carolina Research Center- Site Number : 8400001

    North Charleston, South Carolina, 29406, United States

  • Olympus Clinical Research - Sugar Land- Site Number : 8400009

    Sugar Land, Texas, 77479, United States

  • QUEST Research Institute- Site Number : 8400014

    Bingham Farms, Michigan, 48334, United States

  • Velocity Clinical Research - Norfolk- Site Number : 8400015

    Norfolk, Nebraska, 68701, United States

  • Velocity Clinical Research - Omaha- Site Number : 8400012

    Omaha, Nebraska, 68134, United States

  • Velocity Clinical Research - Salt Lake City- Site Number : 8400011

    West Jordan, Utah, 84088, United States

  • Velocity Clinical Research - San Diego- Site Number : 8400013

    La Mesa, California, 91942, United States

  • Velocity Clinical Research - Springdale- Site Number : 8400010

    Cincinnati, Ohio, 45246, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.